Loading...
Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance
Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2002
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC120648/ https://ncbi.nlm.nih.gov/pubmed/12149356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.8.2942-2944.2002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|